CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (15,220)	$ (18,978)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	22,771	22,421
Amortization of deferred financing costs	919	573
Accretion of below- and amortization of above-market lease liabilities and assets, net	(1,459)	(1,557)
Share-based compensation	64	73
Changes in assets and liabilities:
Straight-line rent receivable	(4,207)	(3,304)
Straight-line rent payable	82	82
Prepaid expenses, other assets and deferred costs	198	(2,663)
Accounts payable, accrued expenses and other liabilities	(3,060)	(1,064)
Deferred revenue	(544)	222
Net cash used in operating activities	(456)	(4,195)
Cash flows from investing activities:
Investments in real estate	(38,265)	0
Deposits for real estate investments		0
Capital expenditures	(5,567)	(6,099)
Net cash used in investing activities	(43,832)	(6,099)
Cash flows from financing activities:
Proceeds from mortgage note payable	55,000	50,000
Payments of financing costs	(3,948)	(2,333)
Distributions paid	0	(7,475)
Repurchases of common stock	0	(7,319)
Net cash provided by financing activities	51,052	32,873
Net change in cash, cash equivalents and restricted cash	6,764	22,579
Cash, cash equivalents and restricted cash, beginning of period	54,801	47,216
Cash, cash equivalents and restricted cash, end of period	61,565	69,795
Cash, cash equivalents and restricted cash, end of period	54,801	47,216
Supplemental Disclosures:
Cash paid for interest	11,176	8,952
Non-Cash Investing and Financing Activities:
Accrued capital expenditures	837	628
Proceeds from mortgage notes payable used to fund acquisition of real estate	51,000	0
Mortgage notes payable released in connection with acquisition of real estate	(51,000)	0
Common stock issued through distribution reinvestment plan	0	4,231
Accrued stock repurchases	$ 0	$ 2,950